logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 9
  • 1
    Lewis, Gary Stephen
    Born in February 1960
    Individual (11 offsprings)
    Officer
    (before 1993-02-24) ~ now
    OF - Director → CIF 0
    Mr Gary Stephen Lewis
    Born in February 1960
    Individual (11 offsprings)
    Person with significant control
    2016-08-01 ~ 2016-08-01
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 2
    Lewis, Henry Thomas John
    Born in April 1988
    Individual (4 offsprings)
    Officer
    2019-08-01 ~ now
    OF - Director → CIF 0
  • 3
    Dancer, Christopher Stephen
    Born in September 1977
    Individual (2 offsprings)
    Officer
    2022-09-28 ~ now
    OF - Director → CIF 0
  • 4
    Maxim, Barry William
    Accountant born in July 1938
    Individual (1 offspring)
    Officer
    1995-05-01 ~ 2001-11-13
    OF - Director → CIF 0
  • 5
    Lewis, Thomas William
    Born in December 1989
    Individual (4 offsprings)
    Officer
    2019-08-01 ~ now
    OF - Director → CIF 0
  • 6
    Lewis, Carmen
    Born in January 1965
    Individual (8 offsprings)
    Officer
    (before 1993-02-24) ~ now
    OF - Director → CIF 0
    Lewis, Carmen
    Individual (8 offsprings)
    Officer
    (before 1993-02-24) ~ now
    OF - Secretary → CIF 0
    Mrs Carmen Lewis
    Born in January 1965
    Individual (8 offsprings)
    Person with significant control
    2016-08-01 ~ 2016-08-01
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 7
    GUARDHEATH SECURITIES LIMITED
    01191856
    2 Duke Street, St James's, London
    Active Corporate (18 parents, 115 offsprings)
    Officer
    1992-02-24 ~ 1992-03-04
    OF - Nominee Director → CIF 0
  • 8
    A1 PHARMACEUTICALS HOLDINGS LIMITED 08511438
    Unit 20-21, Ferry Lane, Rainham, England
    Active Corporate (4 parents, 1 offspring)
    Person with significant control
    2025-12-12 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 9
    M & N SECRETARIES LIMITED
    - now
    M & N GROUP LIMITED - 1999-10-04
    The Quadrant, 118 London Road, Kingston Upon Thames, Surrey
    Active Corporate (27 parents, 760 offsprings)
    Officer
    1992-02-24 ~ 1992-03-04
    OF - Nominee Secretary → CIF 0
parent relation
Company in focus

A1 PHARMACEUTICALS PUBLIC LIMITED COMPANY

Period: 1995-05-17 ~ now
Company number: 02690345
Registered names
A1 PHARMACEUTICALS PUBLIC LIMITED COMPANY - now
MAYLAKE LIMITED - 1995-05-17
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
522024-05-01 ~ 2025-04-30
502023-05-01 ~ 2024-04-30
Turnover/Revenue
60,102,403 GBP2024-05-01 ~ 2025-04-30
55,982,183 GBP2023-05-01 ~ 2024-04-30
Cost of Sales
-52,934,421 GBP2024-05-01 ~ 2025-04-30
-49,624,679 GBP2023-05-01 ~ 2024-04-30
Gross Profit/Loss
7,167,982 GBP2024-05-01 ~ 2025-04-30
6,357,504 GBP2023-05-01 ~ 2024-04-30
Administrative Expenses
-3,970,005 GBP2024-05-01 ~ 2025-04-30
-4,347,820 GBP2023-05-01 ~ 2024-04-30
Operating Profit/Loss
3,197,977 GBP2024-05-01 ~ 2025-04-30
2,009,684 GBP2023-05-01 ~ 2024-04-30
Other Interest Receivable/Similar Income (Finance Income)
234,271 GBP2024-05-01 ~ 2025-04-30
244,215 GBP2023-05-01 ~ 2024-04-30
Profit/Loss on Ordinary Activities Before Tax
3,430,355 GBP2024-05-01 ~ 2025-04-30
2,252,476 GBP2023-05-01 ~ 2024-04-30
Profit/Loss
2,654,887 GBP2024-05-01 ~ 2025-04-30
1,592,889 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment
475,973 GBP2025-04-30
469,406 GBP2024-04-30
Fixed Assets
475,973 GBP2025-04-30
469,406 GBP2024-04-30
Total Inventories
5,420,380 GBP2025-04-30
4,262,110 GBP2024-04-30
Debtors
Current
11,200,873 GBP2025-04-30
12,473,622 GBP2024-04-30
Cash at bank and in hand
7,799,024 GBP2025-04-30
3,828,006 GBP2024-04-30
Current Assets
24,420,277 GBP2025-04-30
20,563,738 GBP2024-04-30
Creditors
Current, Amounts falling due within one year
-4,527,114 GBP2024-04-30
Net Current Assets/Liabilities
16,029,216 GBP2025-04-30
16,036,624 GBP2024-04-30
Total Assets Less Current Liabilities
16,505,189 GBP2025-04-30
16,506,030 GBP2024-04-30
Creditors
Non-current, Amounts falling due after one year
-28,709 GBP2025-04-30
Net Assets/Liabilities
16,362,102 GBP2025-04-30
16,369,022 GBP2024-04-30
Equity
Called up share capital
51,080 GBP2025-04-30
51,080 GBP2024-04-30
51,080 GBP2023-05-01
Retained earnings (accumulated losses)
16,311,022 GBP2025-04-30
16,317,942 GBP2024-04-30
16,345,193 GBP2023-05-01
Equity
16,362,102 GBP2025-04-30
16,369,022 GBP2024-04-30
16,396,273 GBP2023-05-01
Profit/Loss
Retained earnings (accumulated losses)
2,654,887 GBP2024-05-01 ~ 2025-04-30
1,592,889 GBP2023-05-01 ~ 2024-04-30
Dividends Paid
Retained earnings (accumulated losses)
-2,661,807 GBP2024-05-01 ~ 2025-04-30
-1,620,140 GBP2023-05-01 ~ 2024-04-30
Dividends Paid
-2,661,807 GBP2024-05-01 ~ 2025-04-30
-1,620,140 GBP2023-05-01 ~ 2024-04-30
Audit Fees/Expenses
16,600 GBP2024-05-01 ~ 2025-04-30
15,800 GBP2023-05-01 ~ 2024-04-30
Wages/Salaries
2,002,638 GBP2024-05-01 ~ 2025-04-30
1,816,217 GBP2023-05-01 ~ 2024-04-30
Social Security Costs
260,089 GBP2024-05-01 ~ 2025-04-30
237,288 GBP2023-05-01 ~ 2024-04-30
Staff Costs/Employee Benefits Expense
2,303,630 GBP2024-05-01 ~ 2025-04-30
2,780,164 GBP2023-05-01 ~ 2024-04-30
Director Remuneration
392,928 GBP2024-05-01 ~ 2025-04-30
426,917 GBP2023-05-01 ~ 2024-04-30
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
1,936 GBP2024-05-01 ~ 2025-04-30
4,164 GBP2023-05-01 ~ 2024-04-30
Tax Expense/Credit at Applicable Tax Rate
857,589 GBP2024-05-01 ~ 2025-04-30
563,119 GBP2023-05-01 ~ 2024-04-30
Dividends Paid on Shares
2,661,807 GBP2024-05-01 ~ 2025-04-30
1,620,140 GBP2023-05-01 ~ 2024-04-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
849,951 GBP2025-04-30
834,161 GBP2024-04-30
Motor vehicles
584,961 GBP2025-04-30
537,873 GBP2024-04-30
Property, Plant & Equipment - Gross Cost
1,933,310 GBP2025-04-30
1,812,601 GBP2024-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
690,939 GBP2025-04-30
640,075 GBP2024-04-30
Motor vehicles
394,263 GBP2025-04-30
339,550 GBP2024-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
1,457,337 GBP2025-04-30
1,343,195 GBP2024-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Motor vehicles, Owned/Freehold
48,705 GBP2024-05-01 ~ 2025-04-30
Owned/Freehold
99,244 GBP2024-05-01 ~ 2025-04-30
Under hire purchased contracts or finance leases, Plant and equipment
8,890 GBP2024-05-01 ~ 2025-04-30
Motor vehicles, Under hire purchased contracts or finance leases
6,008 GBP2024-05-01 ~ 2025-04-30
Under hire purchased contracts or finance leases
14,898 GBP2024-05-01 ~ 2025-04-30
Property, Plant & Equipment
Plant and equipment
159,012 GBP2025-04-30
194,086 GBP2024-04-30
Motor vehicles
190,698 GBP2025-04-30
198,323 GBP2024-04-30
Under hire purchased contracts or finance leases, Plant and equipment
17,780 GBP2025-04-30
Plant and equipment, Under hire purchased contracts or finance leases
26,670 GBP2024-04-30
Motor vehicles, Under hire purchased contracts or finance leases
36,070 GBP2025-04-30
Under hire purchased contracts or finance leases
53,850 GBP2025-04-30
26,670 GBP2024-04-30
Finished Goods/Goods for Resale
5,420,380 GBP2025-04-30
4,262,110 GBP2024-04-30
Trade Debtors/Trade Receivables
Current
10,344,867 GBP2025-04-30
10,281,940 GBP2024-04-30
Amounts Owed by Group Undertakings
Current
1,561,210 GBP2024-04-30
Other Debtors
Current
818,506 GBP2025-04-30
592,972 GBP2024-04-30
Called-up share capital (not paid)
Current
37,500 GBP2025-04-30
37,500 GBP2024-04-30
Cash and Cash Equivalents
7,799,024 GBP2025-04-30
3,828,006 GBP2024-04-30
Trade Creditors/Trade Payables
Current
3,400,431 GBP2025-04-30
2,438,010 GBP2024-04-30
Amounts owed to group undertakings
Current
3,169,131 GBP2025-04-30
Corporation Tax Payable
Current
167,946 GBP2025-04-30
440,645 GBP2024-04-30
Taxation/Social Security Payable
Current
526,170 GBP2025-04-30
515,088 GBP2024-04-30
Finance Lease Liabilities - Total Present Value
Current
12,992 GBP2025-04-30
6,668 GBP2024-04-30
Other Creditors
Current
1,114,391 GBP2025-04-30
1,126,703 GBP2024-04-30
Creditors
Current
8,391,061 GBP2025-04-30
4,527,114 GBP2024-04-30
Finance Lease Liabilities - Total Present Value
Non-current
28,709 GBP2025-04-30
24,566 GBP2024-04-30
Creditors
Non-current
28,709 GBP2025-04-30
24,566 GBP2024-04-30
Minimum gross finance lease payments owing
24,011 GBP2025-04-30
31,234 GBP2024-04-30
Net Deferred Tax Liability/Asset
-114,378 GBP2025-04-30
-112,442 GBP2024-04-30
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
-1,936 GBP2024-05-01 ~ 2025-04-30
Deferred Tax Liabilities
Accelerated tax depreciation
-114,378 GBP2025-04-30
-112,442 GBP2024-04-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
51,000 shares2025-04-30
51,000 shares2024-04-30
Par Value of Share
Class 1 ordinary share
1.002024-05-01 ~ 2025-04-30
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
10 shares2025-04-30
10 shares2024-04-30
Par Value of Share
Class 2 ordinary share
1.002024-05-01 ~ 2025-04-30
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
10 shares2025-04-30
10 shares2024-04-30
Par Value of Share
Class 3 ordinary share
1.002024-05-01 ~ 2025-04-30
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
10 shares2025-04-30
10 shares2024-04-30
Par Value of Share
Class 4 ordinary share
1.002024-05-01 ~ 2025-04-30
  • A1 PHARMACEUTICALS PUBLIC LIMITED COMPANY
    Info
    MAYLAKE LIMITED - 1995-05-17
    Registered number 02690345
    Unit 20 & 21 Easter Industrial, Park, Ferry Lane South, Rainham, Essex RM13 9BP
    PUBLIC LIMITED COMPANY incorporated on 1992-02-24 (34 years 3 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-07-19
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.